Tech Company Financing Transactions

Rubedo Life Sciences Funding Round

Rubedo Life Sciences closed a $40 million Series A funding round on 4/22/2024. Backers included Ahren Innovation Capital, Khosla Ventures and Italian Angels for Growth.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

228 Oakmead Pkwy.
Sunnyvale, CA 94085
USA

Phone

Undisclosed

Website

www.rubedolife.com

Email Address

[email protected]

Overview

Rubedo Life Sciences is a biopharmaceutical company developing a broad portfolio of innovative therapies engineered to target cells which drive chronic age-related diseases. The Rubedo leadership team is composed of industry leaders and early pioneers in chemistry, technology, and life sciences, with expertise in drug development and commercialization from leading biotech companies.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chairman

Mark Gallop

        

Chief Executive Officer

Marco Quarta

        

Chief Technical Officer

Alex Laslavic

        

Co-Founder

Julian Klein

        

Vice President

Jeffrey Jasper

        

VP - R & D

Alberto Vitari

        

Browse more venture capital transactions:

Prev: 4/21/2024: Orbex venture capital transaction
Next: 4/22/2024: Auxa Health venture capital transaction

Share this article

About Our Venture Capital Transactions Database

We do our best to record every notable VC transaction. VC investment data records on this site are derived from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary